Cipher Pharmaceuticals Inc. (CPH.TO)
Company Info
Highlights
CA$318.24M
CA$0.50
24.84
CA$39.52M
CA$28.43M
CA$6.68M
CA$8.01 - CA$19.69
CA$15.78
0.07%
0.92
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Cipher Pharmaceuticals Inc. (CPH.TO) returned -12.85% year-to-date (YTD) and 43.78% over the past 12 months. Over the past 10 years, CPH.TO returned 0.15% annually, underperforming the S&P 500 benchmark at 10.68%.
CPH.TO
-12.85%
0.65%
-12.36%
43.78%
73.73%
58.44%
0.15%
^GSPC (Benchmark)
-1.34%
5.02%
-3.08%
9.39%
13.76%
14.45%
10.68%
Monthly Returns
The table below presents the monthly returns of CPH.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -5.10% | -10.82% | 5.20% | 6.04% | -7.69% | -12.85% | |||||||
| 2024 | 6.68% | 18.61% | 26.96% | -3.48% | 1.98% | -6.39% | 55.12% | 49.29% | -19.75% | -1.31% | 2.06% | -6.71% | 158.48% |
| 2023 | -10.68% | 10.79% | -13.16% | 3.03% | 13.82% | -7.75% | 4.20% | 6.45% | 7.32% | 2.59% | 44.72% | -12.20% | 44.27% |
| 2022 | -0.56% | 13.07% | 14.07% | -1.32% | 6.25% | -7.56% | -0.45% | 19.63% | 23.66% | -2.16% | 10.41% | 9.71% | 116.95% |
| 2021 | -3.23% | 2.22% | 40.22% | 0.78% | 3.08% | 11.94% | 2.00% | 39.22% | 3.76% | 14.48% | -29.25% | -1.12% | 90.32% |
| 2020 | -30.67% | -11.54% | -23.91% | 35.71% | 29.47% | -2.44% | 15.83% | -17.27% | -6.96% | -7.48% | -16.16% | 12.05% | -38.00% |
| 2019 | 11.70% | 1.57% | -27.84% | -0.00% | -3.57% | -2.96% | -11.45% | 11.21% | 8.53% | -15.00% | 1.68% | 23.97% | -12.28% |
| 2018 | -19.18% | 7.07% | -0.94% | -13.81% | -5.52% | -14.62% | -1.03% | 18.69% | -4.96% | -13.50% | -24.47% | -19.72% | -65.10% |
| 2017 | -3.06% | -3.16% | -0.00% | -3.26% | 26.07% | 1.60% | -5.09% | -3.88% | -8.65% | -8.84% | 15.47% | -2.00% | -0.00% |
| 2016 | -10.79% | 11.40% | -3.26% | 18.91% | 2.56% | -11.30% | -2.52% | -15.20% | -10.04% | -3.39% | -19.59% | 25.64% | -24.50% |
| 2015 | 4.24% | -18.16% | -19.73% | 9.24% | -1.92% | -13.18% | -0.37% | -33.77% | -29.69% | 9.09% | 13.33% | 6.05% | -61.25% |
| 2014 | 0.65% | 3.98% | -6.05% | 10.91% | -6.40% | 11.52% | 2.72% | 19.01% | 8.64% | 20.85% | 8.56% | 9.12% | 116.41% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 77, CPH.TO is among the top 23% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cipher Pharmaceuticals Inc. (CPH.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cipher Pharmaceuticals Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cipher Pharmaceuticals Inc. was 97.90%, occurring on Mar 18, 2020. Recovery took 1117 trading sessions.
The current Cipher Pharmaceuticals Inc. drawdown is 34.28%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.9% | Dec 29, 2014 | 1311 | Mar 18, 2020 | 1117 | Aug 29, 2024 | 2428 |
| -94.14% | Feb 15, 2006 | 679 | Oct 27, 2008 | 1179 | Jul 9, 2013 | 1858 |
| -71.62% | Feb 26, 2004 | 456 | Dec 6, 2005 | 35 | Jan 27, 2006 | 491 |
| -42.5% | Sep 3, 2024 | 130 | Mar 10, 2025 | — | — | — |
| -33.09% | Sep 17, 2013 | 10 | Sep 30, 2013 | 216 | Aug 11, 2014 | 226 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cipher Pharmaceuticals Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Cipher Pharmaceuticals Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -9.0%.
Valuation
The Valuation section provides an overview of how Cipher Pharmaceuticals Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CPH.TO, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CPH.TO has a P/E ratio of 24.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CPH.TO compared to other companies in the Drug Manufacturers - Specialty & Generic industry. CPH.TO currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CPH.TO relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CPH.TO has a P/S ratio of 9.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CPH.TO in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CPH.TO has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |